Discovery of SCH446211 (SCH6): A New Ketoamide Inhibitor of the HCV NS3 Serine Protease and HCV Subgenomic RNA Replication
- 5 April 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (9) , 2750-2757
- https://doi.org/10.1021/jm060077j
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P′2 moiety with improved potencyBioorganic & Medicinal Chemistry Letters, 2005
- Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as Hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complexBioorganic & Medicinal Chemistry Letters, 2004
- Erratum: Corrigendum: An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNature, 2003
- Asymmetric Hydrogenations for the Synthesis of Boc-Protected 4-Alkylprolinols and ProlinesThe Journal of Organic Chemistry, 2003
- Recent developments in the discovery of hepatitis C virus serine protease inhibitors – towards a new class of antiviral agents?Expert Opinion on Investigational Drugs, 2003
- The identification of α-ketoamides as potent inhibitors of hepatitis c virus nS3-4a proteinaseBioorganic & Medicinal Chemistry Letters, 2001
- Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In VivoJournal of Virology, 2000
- Hepatitis C virus NS3/4A proteaseAntiviral Research, 1998
- Hepatitis C: progress and problemsClinical Microbiology Reviews, 1994
- Stereoselective Double Alkylation of Ethyl N-Boc-pyroglutamateThe Journal of Organic Chemistry, 1994